Cargando…
Circulating Cystatin C Is an Independent Risk Marker for Cardiovascular Outcomes, Development of Renal Impairment, and Long‐Term Mortality in Patients With Stable Coronary Heart Disease: The LIPID Study
BACKGROUND: Elevated plasma cystatin C levels reflect reduced renal function and increased cardiovascular risk. Less is known about whether the increased risk persists long‐term or is independent of renal function and other important biomarkers. METHODS AND RESULTS: Cystatin C and other biomarkers w...
Autores principales: | West, Malcolm, Kirby, Adrienne, Stewart, Ralph A., Blankenberg, Stefan, Sullivan, David, White, Harvey D., Hunt, David, Marschner, Ian, Janus, Edward, Kritharides, Leonard, Watts, Gerald F., Simes, John, Tonkin, Andrew M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075058/ https://www.ncbi.nlm.nih.gov/pubmed/35179040 http://dx.doi.org/10.1161/JAHA.121.020745 |
Ejemplares similares
-
B‐Type Natriuretic Peptide and Long‐Term Cardiovascular Mortality in Patients With Coronary Heart Disease
por: Stewart, Ralph A. H., et al.
Publicado: (2022) -
Semi-parametric risk prediction models for recurrent cardiovascular events in the LIPID study
por: Cui, Jisheng, et al.
Publicado: (2010) -
Changes in Lipoprotein‐Associated Phospholipase A2 Activity Predict Coronary Events and Partly Account for the Treatment Effect of Pravastatin: Results From the Long‐term Intervention with Pravastatin in Ischemic Disease Study
por: White, Harvey D., et al.
Publicado: (2013) -
Common genetic variants do not predict recurrent events in coronary heart disease patients
por: Thompson, P. L., et al.
Publicado: (2022) -
Which lipid measurement should we monitor? An analysis of the LIPID study
por: Glasziou, Paul P, et al.
Publicado: (2014)